Researchers studying the protective factors in the stomach in the early 1990s named the parent molecule Body Protection Compound, abbreviated BPC
LEADER (liraglutide) : In the LEADER trial, liraglutide lowered major cardiovascular events by 31% and all-cause mortality by 26% in type 2 diabetes patients with chronic kidney disease, compared with placebo
New York: Academic Press, 1992: 381400 Bohmer T, Bergrem H, Eiklid K
It helps to picture the chemistry
Neuroscience 123:131145 Mller L, Frhlich K, Bhm V (2011) Comparative antioxidant activities of carotenoids measured by ferric reducing antioxidant power (FRAP), ABTS bleaching assay (TEAC), DPPH assay and peroxyl radical scavenging assay
How Does PT-141 Work